Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality?

Nuclear Medicine Communications

Volumn 34, Issue 5, 2013, Pages 417-425

  Ohnona, Jessica ^a   Michaud, Laure ^a   Balogova, Sona ^a   Paycha, Frédéric ^a   Nataf, Valérie ^a   Chauchat, Paul ^a   Talbot, Jean Noël ^a   Kerrou, Khaldoun ^a  

^a HÔPITAL TENON   (France)

Author keywords

18F sodium fluoride; dosimetry; low dose; PET CT; time of flight

Indexed keywords

OXIDRONATE TECHNETIUM TC 99M; SODIUM FLUORIDE F 18;

ADULT; AGED; ARTICLE; BODY MASS; BONE METASTASIS; BONE SCINTISCANNING; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; LOW DRUG DOSE; MALE; PRACTICE GUIDELINE; RADIATION DOSE;

ADULT; AGED; AGED, 80 AND OVER; BONE AND BONES; BONE NEOPLASMS; DIPHOSPHONATES; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; SENSITIVITY AND SPECIFICITY; SODIUM FLUORIDE; TECHNETIUM; TIME FACTORS;

EID: 84876405965     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32835fcd9d     Document Type: Article

References (27)

1. Segall G, Delbeke D, Stabin MG, E Men-Sapir E, Fair J, Sajdak R, et a.l. SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0. J Nucl Med 2010; 51:1813-20.
2. Schirrmeister H, Guhlmann A, Elsner K, Kotzerke J, Glatting G, Rentschler M, et a.l. Sensiti Mity in detecting osseous lesions depends on anatomic localization: Planar bone scintigraphy Mersus 18F PET. J Nucl Med 1999; 40:1623-1629.
3. Schirrmeister H, Guhlmann A, Kotzerke J, Santjohanser C, Kuhn T, Kreienberg R, et a.l. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 1999; 17:2381-2389.
4. Hetzel M, Arslandemir C, Konig HH, Buck AK, Nussle K, Glatting G, et a.l. F-18 NaF PET for detection of bone metastases in lung cancer: Accuracy, cost-effecti Meness, and impact on patient management. J Bone Miner Res 2003; 18:2206-2214.
5. E Men-Sapir E, Metser U, Mishani E, Lie Mshitz G, Lerman H, Leibo Mitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of- Miew SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med 2006; 47:287-297.
6. Grant FD, Fahey FH, Packard AB, Da Mis RT, Ala Mi A, Tre Mes S.T. Skeletal PET with 18F-fluoride: Applying new technology to an old tracer. J Nucl Med 2008; 49:68-78.
7. AFSSAPS. IASOflu, summary of product characteristics; 2008. A Mailable at: Http://afssaps-prd.afssaps.fr/php/ecodex/frames.php?specid= 65408195& typedoc= R&ref= R0186087.htm. (Accessed 20 February 2013).
8. SNM guidelines, endorsement by EANM. Sodium 18F-fluoride with PET/CT bone scans; 2012. A Mailable at: Http://www.eanm.org/publications/ guidelines/index.php?na MId =37. (Accessed 20 February 2013).
9. Donohoe KJ, Brown ML, Collier BD, Carretta R.F. Society of Nuclear Medicine Procedure Guideline for Bone Scintigraphy; 2003. A Mailable at: Http://interacti Me.snm.org/index.cfm?PageID=1110&FileID=1335. (Accessed 20 February 2013).
10. Karp JS, Surti S, Daube-Witherspoon ME, Muehllehner G. Benefit of time-of-flight in PET: Experimental and clinical results. J Nucl Med 2008; 49:462-470.
11. Surti S, Karp JS, Popescu LM, Daube-Witherspoon ME, Werner M. In Mestigation of time-of-flight benefit for fully 3-D PET. IEEE Trans Med Imaging 2006; 25:529-538.
12. Surti S, Scheuermann J, El Fakhri G, Daube-Witherspoon ME, Lim R, Abi-Hatem N, et a.l. Impact of time-of-flight PET on whole-body oncologic studies: A human obser Mer lesion detection and localization study. J Nucl Med 2011; 52:712-719.
13. El Fakhri G, Surti S, Trott CM, Scheuermann J, Karp J.S. Impro Mement in lesion detection with whole-body oncologic time-of-flight PET. J Nucl Med 2011; 52:347-353.
14. Surti S, Kuhn A, Werner ME, Perkins AE, Kolthammer J, Karp J.S. Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med 2007; 48:471-480.
15. Lois C, Jakoby BW, Long MJ, Hubner KF, Barker DW, Casey ME, et a.l. An assessment of the impact of incorporating time-of-flight information into clinical PET/CT imaging. J Nucl Med 2010; 51:237-245.
16. Murray I, Kalemis A, Glennon J, Hasan S, Quraishi S, Beyer T, et a.l. Time-offlight PET/CT using low-acti Mity protocols: Potential implications for cancer therapy monitoring. Eur J Nucl Med Mol Imaging 2010; 37:1643-1653.
17. Alessio AM, Sammer M, Phillips GS, Manchanda M, Mohr BC, Parisi M.T. E Maluation of optimal acquisition duration or injected acti Mity for pediatric 18F-FDG PET/CT. J Nucl Med 2011; 52: 1028-1034.
18. Wahl RL, Jacene H, Kasamon Y, Lodge M.A. From RECIST to PERCIST: E Mol Ming considerations for PET response criteria in solid tumors. J Nucl Med 2009; 50 (Suppl 1):122S-150SS.
19. E Men-Sapir E, Metser U, Flusser G, Zuriel L, Kollender Y, Lerman H, et a.l. Assessment of malignant skeletal disease: Initial experience with 18F-fluoride PET/CTand comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med 2004; 45:272-278.
20. Schiepers C, Nuyts J, Bormans G, Dequeker J, Bouillon R, Mortelmans L, et a.l. Fluoride kinetics of the axial skeleton measured in Mi Mo with fluorine-18- fluoride PET. J Nucl Med 1997; 38:1970-1976.
21. Yen RF, Chen CY, Cheng MF,Wu YW, Shiau YC,Wu K, et a.l. The diagnostic and prognostic effecti Meness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients. Nucl Med Commun 2010; 31:637-645.
22. Huda W, Ogden KM, Khorasani M.R. Con Merting dose-length product to effecti Me dose at C.T. Radiology 2008; 248:995-1003.
23. Hurwitz LM, Reiman RE, Yoshizumi TT, Goodman PC, Tonche Ma G, Nguyen G, et a.l. Radiation dose from contemporary cardiothoracic multidetector CT protocols with an anthropomorphic female phantom: Implications for cancer induction. Radiology 2007; 245:742-750.
24. Hara N, Onoguchi M, Takenaka K, Matsubara K, Ujita H, Kenko Y. Assessment of patient exposure to X-radiation from SPECT/CT scanners. J Nucl Med Technol 2010; 38:138-148.
25. Sil Ma AC, Lawder HJ, Hara A, Kujak J, Pa Mlicek W. Inno Mations in CT dose reduction strategy: Application of the adapti Me statistical iterati Me reconstruction algorithm. AJR Am J Roentgenol 2010; 194:191-199.
26. Tayama Y, Takahashi N, Oka T, Takahashi A, Aratake M, Saitou T, et a.l. Clinical e Maluation of the effect of attenuation correction technique on 18F-fluoride PET images. Ann Nucl Med 2007; 21:93-99.
27. Nagarajah J, Dannat T, Hartung M, Bockisch A, Rosenbaum-Krumme S. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction. Nuklearmedizin 2012; 51:84-87.